Table 2

Solutia mortality surveillance standardised mortality ratios (SMR, 95% CIs) for hourly and salaried workers for entire population and ⩾20 years induction latency period

Cause of death (ICD-9)Hourly workersSalaried workers
Entire population SMR (95% CI)⩾20 Induction latency SMR (95% CI)Entire population SMR(95% CI)⩾20 Induction latency SMR (95% CI)
Men:
 All causes (001–999)0.8 (0.8 to 0.9)0.8 (0.8 to 0.9)0.5 (0.5 to 0.5)0.5 (0.5 to 0.6)
 All cancers (140–208)0.9 (0.8 to 1.0)0.9 (0.8 to 1.0)0.6 (0.6 to 0.7)0.6 (0.6 to 0.7)
 Oesophagus (150)0.8 (0.4 to 1.5)1.0 (0.5 to 1.7)0.3 (0.1 to 0.8)0.3 (0.0 to 0.8)
 Stomach (151)1.0 (0.5 to 1.6)1.0 (0.5 to 1.7)0.4 (0.1 to 0.9)0.3 (0.0 to 0.8)
 Large intestine (153)1.2 (0.9 to 1.6)1.1 (0.8 to 1.6)0.8 (0.6 to 1.2)0.9 (0.6 to 1.2)
 Liver and biliary passages (155–156)0.6 (0.2 to 1.2)0.7 (0.2 to 1.5)0.2 (0.0 to 0.6)0.1 (0.0 to 0.6)
 Larynx (161)0.0 (0.0 to 0.6)0.0 (0.0 to 0.7)0.3 (0.0 to 1.1)0.2 (0.0 to 1.0)
 Bronchus, trachea, lung (162)0.9 (0.8 to 1.1)0.9 (0.8 to 1.1)0.6 (0.5 to 0.7)0.6 (0.5 to 0.7)
 All other respiratory (160,163,164,165)0.0 (0.0 to 0.5)0.0 (0.0 to 5.8)0.2 (0.0 to 0.8)0.1 (0.0 to 0.8)
 Prostate (185)1.1 (0.7 to 1.6)1.0 (0.7 to 1.5)0.6 (0.4 to 1.0)0.6 (0.3 to 0.9)
 Bladder (188,189.3,189.4,189.8,189.9)0.8 (0.3 to 1.6)0.6 (0.2 to 1.4)0.5 (0.2 to 1.3)0.6 (0.2 to 1.4)
 Malignant melanoma of skin (172)0.7 (0.2 to 1.7)0.6 (0.1 to 1.7)0.9 (0.4 to 1.6)0.8 (0.3 to 1.7)
 Bone (170)1.2 (0.0 to 6.6)0.0 (0.0 to 6.4)0.0 (0.0 to 3.2)0.0 (0.0 to 5.0)
 Leukaemia (204–208)1.8 (1.1 to 2.6)1.5 (0.8 to 2.4)0.7 (0.4 to 1.3)0.7 (0.4 to 1.4)
 All heart disease (390–398,402,404,410–429)0.9 (0.8 to 1.0)0.9 (0.8 to 1.0)0.6 (0.5 to 0.6)0.6 (0.5 to 0.6)
 Non-malignant respiratory disease (460–519)0.5 (0.3 to 0.6)0.5 (0.4 to 0.7)0.3 (0.2 to 0.5)0.3 (0.2 to 0.5)
 Motor vehicle accidents (E810–825)1.0 (0.7 to 1.4)1.1 (0.6 to 1.7)0.3 (0.2 to 0.5)0.6 (0.3 to 1.0)
 All other accidents (E800–807,E826–949)0.6 (0.4 to 0.9)0.7 (0.4 to 1.1)0.3 (0.2 to 0.5)0.4 (0.2 to 0.7)
Women:
 All causes (001–999)0.7 (0.6 to 0.8)0.6 (0.5 to 0.8)0.6 (0.5 to 0.7)0.7 (0.5 to 0.8)
 All cancers (140–208)0.7 (0.5 to 0.9)0.6 (0.4 to 0.9)0.9 (0.7 to 1.0)0.8 (0.6 to 1.1)
 Oesophagus (150)0.0 (0.0 to 5.8)0.0 (0.0 to 8.3)1.1 (0.0 to 6.2)1.8 (0.0 to 10.2)
 Stomach (151)0.9 (0.0 to 5.0)1.3 (0.0 to 7.5)1.1 (0.1 to 3.9)2.0 (0.2 to 7.1)
 Large intestine (153)1.1 (0.3 to 2.5)0.9 (0.2 to 2.5)0.9 (0.4 to 1.8)0.9 (0.2 to 2.1)
 Liver and biliary passages (155–156)0.0 (0.0 to 3.0)0.0 (0.0 to 4.2)0.0 (0.0 to 1.8)0.0 (0.0 to 3.1)
 Larynx (161)0.0 (0.0 to 13.9)0.0 (0.0 to 19.2)0.0 (0.0 to 9.2)0.0 (0.0 to 15.1)
 Bronchus, trachea, lung (162)0.9 (0.5 to 1.5)0.8 (0.4 to 1.5)0.9 (0.5 to 1.3)1.0 (0.6 to 1.6)
 All other respiratory (160,163,164,165)0.0 (0.0 to 9.2)0.0 (0.0 to 13.2)0.0 (0.0 to 5.8)0.0 (0.0 to 10.3)
 Breast (174,175)0.5 (0.2 to 1.0)0.5 (0.2 to 1.3)0.7 (0.4 to 1.1)0.4 (0.1 to 0.8)
 Bladder (188,189.3,189.4,189.8,189.9)0.0 (0.0 to 8.0)0.0 (0.0 to 10.5)0.0 (0.0 to 4.9)0.0 (0.0 to 7.6)
 Malignant melanoma of skin (172)0.0 (0.0 to 4.7)0.0 (0.0 to 7.8)0.6 (0.0 to 3.4)1.4 (0.0 to 7.6)
 Bone (170)0.0 (0.0 to 31.3)0.0 (0.0 to 58.6)0.0 (0.0 to 16.5)0.0 (0.0 to 42.2)
 Leukaemia (204–208)1.7 (0.3 to 4.9)1.8 (0.2 to 6.5)1.5 (0.5 to 3.5)1.9 (0.4 to 5.5)
 All heart disease (390–398,402,404,410–429)0.5 (0.3 to 0.5)0.5 (0.3 to 0.9)0.7 (0.4 to 1.0)0.7 (0.4 to 1.0)
 Non-malignant respiratory disease (460–519)0.8 (0.3 to 1.5)0.8 (0.3 to 1.7)0.7 (0.3 to 1.2)0.8 (0.4 to 1.6)
 Motor vehicle accidents (E810–825)1.7 (0.7 to 3.5)0.8 (0.0 to 4.2)0.5 (0.2 to 1.2)0.5 (0.0 to 2.6)
 All other accidents (E800–807,E826–949)0.7 (0.1 to 2.4)0.0 (0.0 to 2.8)0.6 (0.2 to 1.7)0.5 (0.0 to 2.8)
People, person-years, and deaths:
 People at risk1502668532796413354
 Person-years18965870377336106130526
 Total deaths132510631079845